Source: International Congress 2018 – Respiratory medicine meets rheumatology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tyndall (Florence, Italy). Treating systemic sclerosis with lung involvement: from observation to stem cell transplantation. International Congress 2018 – Respiratory medicine meets rheumatology

Member's Comments

No comment yet.

Related content which might interest you: Systemic sclerosis and bilateral lung transplantation: a single centre experience Source: Eur Respir J 2010; 36: 893-900 Year: 2010 Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT) Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease Source: ERS Lung Science Conference 2017 Year: 2017 Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Restrictive chronic lung function decline after haematopoietic stem cell transplantation Source: Eur Respir J 2016; 47: 336-339 Year: 2016 Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation Source: Eur Respir J 2013; 41: 479-483 Year: 2013 Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Pretransplant lung function tests in patients with malignant hemopathy undergoing stem cell transplantation. Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Undifferentiated connective tissue disease at risk for systemic sclerosis: is heart function already impaired? Source: International Congress 2017 – PAH and CTEPH Year: 2017 Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004 Lung transplantation for systemic sclerosis and other connective tissue diseases Source: International Congress 2017 – Difficult indications for lung transplantation Year: 2017 Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis Year: 2010 Pulmonary veno-occlusive disease after hematopoietic stem cell transplantation Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Lung transplantation: the ideal treatment for diffuse disease? Source: Annual Congress 2006 - Up to date management of bronchiectasis Year: 2006 Early lung function alterations after allogeneic hematopoietic stem cell transplantation Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017 Year: 2018 The impact of bone marrow stem cells therapy in pulmonary and extrapulmonary acute lung injury Source: Annual Congress 2008 - Pathophysiology of acute lung injury Year: 2008